Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study

Abstract Background Sildenafil citrate (SC) attenuates endothelial dysfunction. However, its effects on diabetic retinopathy (DR), which is mainly a microvascular disease, remain unclear. Vascular endothelial growth factor (VEGF) is known to be a critical mediator of DR. Therefore, we investigated t...

Full description

Bibliographic Details
Main Authors: Osama A. Sorour, Elsayed Nassar, Naglaa Sarhan, Noha El-Anwar, Reem A ElKholy, Dina M. Tahoon, Aalaa Sweilam, Dina Tadros
Format: Article
Language:English
Published: BMC 2023-07-01
Series:International Journal of Retina and Vitreous
Subjects:
Online Access:https://doi.org/10.1186/s40942-023-00480-x
_version_ 1797774041365348352
author Osama A. Sorour
Elsayed Nassar
Naglaa Sarhan
Noha El-Anwar
Reem A ElKholy
Dina M. Tahoon
Aalaa Sweilam
Dina Tadros
author_facet Osama A. Sorour
Elsayed Nassar
Naglaa Sarhan
Noha El-Anwar
Reem A ElKholy
Dina M. Tahoon
Aalaa Sweilam
Dina Tadros
author_sort Osama A. Sorour
collection DOAJ
description Abstract Background Sildenafil citrate (SC) attenuates endothelial dysfunction. However, its effects on diabetic retinopathy (DR), which is mainly a microvascular disease, remain unclear. Vascular endothelial growth factor (VEGF) is known to be a critical mediator of DR. Therefore, we investigated the effects of SC on diabetic retina by measuring VEGF levels. Methods In this study, twenty-eight rats were divided into the following groups: group I, the control group; group II, rats with streptozotocin-induced diabetes; group III, rats with streptozotocin-induced diabetes receiving daily oral sildenafil at 1 mg/kg; and group IV, rats with streptozotocin-induced diabetes receiving high-dose daily sildenafil at 2.5 mg/kg. After 3 months, VEGF was measured in the retina specimen in one eye and the vitreous body in the other eye by immunohistochemistry and enzyme-linked immunosorbent assay, respectively. Results We found that VEGF expression in the retina was low in all rats from groups I and IV and in 30% of rats from group III; 80% of rats in group II demonstrated high VEGF expression in the retinae (P < 0.001). VEGF concentrations in the vitreous body samples were 32 ± 2, 61 ± 4, 44 ± 5, and 36 ± 3 pg/l in groups I–IV, respectively (P < 0.001). Conclusion VEGF decreased significantly in the eyes of diabetic rats after chronic oral sildenafil citrate treatment. SC may have a modifying/attenuating effect on DR. However, further studies are needed to evaluate its use as an adjunctive treatment.
first_indexed 2024-03-12T22:15:10Z
format Article
id doaj.art-a70f1af323ca4d8d8dad20f7f370a1c8
institution Directory Open Access Journal
issn 2056-9920
language English
last_indexed 2024-03-12T22:15:10Z
publishDate 2023-07-01
publisher BMC
record_format Article
series International Journal of Retina and Vitreous
spelling doaj.art-a70f1af323ca4d8d8dad20f7f370a1c82023-07-23T11:21:55ZengBMCInternational Journal of Retina and Vitreous2056-99202023-07-01911710.1186/s40942-023-00480-xChronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot studyOsama A. Sorour0Elsayed Nassar1Naglaa Sarhan2Noha El-Anwar3Reem A ElKholy4Dina M. Tahoon5Aalaa Sweilam6Dina Tadros7Department of Ophthalmology, Faculty of Medicine, Tanta UniversityDepartment of Ophthalmology, Faculty of Medicine, Tanta UniversityDepartment of Histology, Faculty of Medicine, Tanta UniversityDepartment of Pathology, Faculty of Medicine, Tanta UniversityDepartment of Pharmacology, Faculty of Medicine, Tanta UniversityDepartment of Pharmacology, Faculty of Medicine, Tanta UniversityDepartment of Ophthalmology, Faculty of Medicine, Tanta UniversityDepartment of Ophthalmology, Faculty of Medicine, Tanta UniversityAbstract Background Sildenafil citrate (SC) attenuates endothelial dysfunction. However, its effects on diabetic retinopathy (DR), which is mainly a microvascular disease, remain unclear. Vascular endothelial growth factor (VEGF) is known to be a critical mediator of DR. Therefore, we investigated the effects of SC on diabetic retina by measuring VEGF levels. Methods In this study, twenty-eight rats were divided into the following groups: group I, the control group; group II, rats with streptozotocin-induced diabetes; group III, rats with streptozotocin-induced diabetes receiving daily oral sildenafil at 1 mg/kg; and group IV, rats with streptozotocin-induced diabetes receiving high-dose daily sildenafil at 2.5 mg/kg. After 3 months, VEGF was measured in the retina specimen in one eye and the vitreous body in the other eye by immunohistochemistry and enzyme-linked immunosorbent assay, respectively. Results We found that VEGF expression in the retina was low in all rats from groups I and IV and in 30% of rats from group III; 80% of rats in group II demonstrated high VEGF expression in the retinae (P < 0.001). VEGF concentrations in the vitreous body samples were 32 ± 2, 61 ± 4, 44 ± 5, and 36 ± 3 pg/l in groups I–IV, respectively (P < 0.001). Conclusion VEGF decreased significantly in the eyes of diabetic rats after chronic oral sildenafil citrate treatment. SC may have a modifying/attenuating effect on DR. However, further studies are needed to evaluate its use as an adjunctive treatment.https://doi.org/10.1186/s40942-023-00480-xVEGFSildenafilPDEI-5Diabetic retinopathyELISAImmunohistochemistry
spellingShingle Osama A. Sorour
Elsayed Nassar
Naglaa Sarhan
Noha El-Anwar
Reem A ElKholy
Dina M. Tahoon
Aalaa Sweilam
Dina Tadros
Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study
International Journal of Retina and Vitreous
VEGF
Sildenafil
PDEI-5
Diabetic retinopathy
ELISA
Immunohistochemistry
title Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study
title_full Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study
title_fullStr Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study
title_full_unstemmed Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study
title_short Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study
title_sort chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats a pilot study
topic VEGF
Sildenafil
PDEI-5
Diabetic retinopathy
ELISA
Immunohistochemistry
url https://doi.org/10.1186/s40942-023-00480-x
work_keys_str_mv AT osamaasorour chronicsildenafilcitrateusedecreasesretinalvascularendothelialgrowthfactorexpressionindiabeticratsapilotstudy
AT elsayednassar chronicsildenafilcitrateusedecreasesretinalvascularendothelialgrowthfactorexpressionindiabeticratsapilotstudy
AT naglaasarhan chronicsildenafilcitrateusedecreasesretinalvascularendothelialgrowthfactorexpressionindiabeticratsapilotstudy
AT nohaelanwar chronicsildenafilcitrateusedecreasesretinalvascularendothelialgrowthfactorexpressionindiabeticratsapilotstudy
AT reemaelkholy chronicsildenafilcitrateusedecreasesretinalvascularendothelialgrowthfactorexpressionindiabeticratsapilotstudy
AT dinamtahoon chronicsildenafilcitrateusedecreasesretinalvascularendothelialgrowthfactorexpressionindiabeticratsapilotstudy
AT aalaasweilam chronicsildenafilcitrateusedecreasesretinalvascularendothelialgrowthfactorexpressionindiabeticratsapilotstudy
AT dinatadros chronicsildenafilcitrateusedecreasesretinalvascularendothelialgrowthfactorexpressionindiabeticratsapilotstudy